NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Contingency Management in HIV Care for Both Stimulant Use & ART Adherence

CompletedNA

Sponsor: University of California, San Francisco

Conditions: Stimulant Use (Diagnosis), Hiv

Interventions: Contingency management

Countries: United States

Methamphetamine use and associated sequelae have been rising, and represent a major barrier to successful control of the HIV epidemic. Methamphetamine use is associated with poor adherence to antiretroviral therapy for HIV, and the investigators propose a trial of contingency management (providing incentives for behavioral change) targeting both reduced methamphetamine use and improved adherence to HIV medications. The investigators will utilize a real-time, point-of-care urine assay for both outcomes, aiming to evaluate feasibility, acceptability and preliminary effectiveness of HIV care-based contingency management. Hair levels will also be studied as a quantitative outcome for reduction in methamphetamine use.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Stimulant use disorder
* Living with HIV or risk for HIV
* Suboptimal ART adherence (treatment or prevention)

Exclusion Criteria:

* Unable to provide urine testing weekly

Locations (1)

San Francisco, California, United States